Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease

Vicente E. Torres(Mayo Clinic), Xiaofang Wang(Mayo Clinic), Qi Qian(Mayo Clinic), Stefan Somlo(Yale University), Peter C. Harris(Mayo Clinic), Vincent H. Gattone(Indiana University School of Medicine)
Nature Medicine
February 29, 2004
10.1038/nm1004
Cited by 481

Abstract

Related Papers

Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells
Surya M. Nauli, Francis J. Alenghat, Ying Luo et al.|Nature Genetics|2003|2k
Polycystin-2 is an intracellular calcium release channel
Peter Koulen, Yiqiang Cai, Lin Geng et al.|Nature Cell Biology|2002|714
Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist
Vincent H. Gattone, Xiaofang Wang, Peter C. Harris et al.|Nature Medicine|2003|669
Somatic Inactivation of Pkd2 Results in Polycystic Kidney Disease
Guanqing Wu, Vivette D. D’Agati, Yiqiang Cai et al.|Cell|1998|571
cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway
Tamio Yamaguchi, Jill C. Pelling, Nadja T. Ramaswamy et al.|Kidney International|2000|352